MetaCap

Acadia Healthcare (ACHC) vs Caris Life Sciences (CAI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Acadia Healthcare (ACHC) has outperformed Caris Life Sciences (CAI) over the past year, gaining 127.9% versus a loss of 27.0%. Caris Life Sciences is the larger company by market cap ($5.04 billion vs $3.22 billion), about 1.6 times the size. On valuation, Acadia Healthcare trades at a lower forward P/E (17.1x vs 64.9x for Caris Life Sciences).

Caris Life Sciences converts more of its revenue into profit, with a net margin of -8.4% versus -33.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACHC+127.93%CAI-27.02%
+165%+58%-49%
Nov 21, 20251 yearNov 20, 2026
ACHC+60.48%CAI-35.49%
+81%+14%-53%
Jun 16, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACHC versus CAI key metrics
MetricACHCCAI
Share price$34.60$17.58
Market cap$3.22B$5.04B
1-day change+0.38%-5.18%
YTD return+143.83%-34.84%
1-year return+127.93%-27.02%
5-year return-40.15%—
P/E ratio (TTM)—10.59
Forward P/E17.0764.87
EPS (TTM)$-12.44$1.66
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$3.31B$812.03M
Revenue growth (YoY)+5.04%+96.97%
Net income (latest FY)$-1.10B$-68.09M
Operating margin—5.56%
Net margin-33.29%-8.38%
52-week high$39.70$36.50
52-week low$11.43$14.19
Distance from 52-week high-12.85%-51.84%
Analyst consensusbuybuy
Avg. price target upside+12.92%+94.71%
Average volume1.84M4.61M
Shares outstanding92.97M286.78M
Employees19,0001,846
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ACHC has outperformed CAI by 155.0 percentage points over the past year.
  • Caris Life Sciences is more profitable, keeping -8.4 cents of every revenue dollar as net income versus -33.3 cents for Acadia Healthcare.
  • Caris Life Sciences grew revenue faster in its latest fiscal year (+96.97% vs +5.04%).

About Acadia Healthcare

ACHC stock →

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.

Health Care · Medical Specialities · 19,000 employees

About Caris Life Sciences

CAI stock →

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms.

Health Care · Medical Specialities · 1,846 employees

ACHC vs CAI FAQ

Which is bigger, Acadia Healthcare or Caris Life Sciences?

Caris Life Sciences (CAI) is larger, with a market capitalization of $5.04B compared with $3.22B for Acadia Healthcare (ACHC).

Which stock has performed better over the past year, ACHC or CAI?

ACHC returned +127.93% over the past 12 months, compared with -27.02% for CAI (price return, excluding dividends). Past performance does not predict future results.

Are Acadia Healthcare and Caris Life Sciences in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons